DOCSLIB.ORG

Protein Detection by Sequencing: Towards a Definitive Cellular

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Protein Detection by Sequencing: Towards a Definitive Cellular PROTEIN DETECTION BY SEQUENCING: TOWARDS A DEFINITIVE CELLULAR PHENOTYPE Methods that allow researchers to simultaneously sequence RNA and detect extracellular proteins in individual cells reveal new cell types and states associated with disease. For by CUSTOM MEDIA ADVERTISEMENT FEATURE DNA-tagged antibodies allow for detection of proteins with results read by sequencing. ELLA MARU STUDIO, INC. PROTEIN DETECTION BY SEQUENCING: TOWARDS A DEFINITIVE CELLULAR PHENOTYPE Methods that allow researchers to SIMULTANEOUSLY SEQUENCE RNA AND DETECT EXTRACELLULAR PROTEINS in individual cells reveal new cell types and states associated with disease. Advertiser retains sole responsibility for content ADVERTISEMENT FEATURE roteins are the workhorses A major advantage of comprehensive reference To validate CITE-seq, the of the cell, involved in CITE-seq and REAP-seq is maps of all 37 trillion cells in developers at the New York P almost every aspect of that, with an appropriate the human body. Genome Center and scientists structure and function. Protein antibody, they can detect Now, by providing details at NYU Lagone Health used expression patterns help define a protein of interest even if about both protein and RNA it to simultaneously profile a cell’s identity and state. the RNA that encodes it is in expression, CITE-seq and the transcriptome and 13 RNA transcripts are often low abundance. “CITE-seq REAP-seq allow researchers cell-surface proteins of used as a surrogate for protein gives us more confidence in to fill in the gaps left by flow human and mouse immune expression, but it has long been the presence of a marker of cytometry or single cell cells. They showed that understood that the relationship interest in a given cell type,” RNA-seq. CITE-seq not only correctly between abundance of proteins Rahman explains. “Advances in multimodal identified different immune and mRNA is not one-to- For decades, researchers single cell sequencing cell populations, it enhanced one. There are differences have used flow cytometry to methods are providing an the characterization of known caused by regulation of post- detect proteins in single cells unprecedented opportunity subtypes. Using CITE-seq transcriptional, translational and characterize cell types to look at biological they were able to identify and protein degradation. based on protein expression mechanisms of disease,” says subsets of natural killer “It has been eye-opening patterns. Flow cytometry Tom Maniatis, a renowned cells with different roles to see how much we might be relies on antibodies biochemist and biophysicist in regulating the immune missing by using conventional directed against proteins of leading Columbia University’s response in disease states sequencing,” concedes Adeeb interest. This means that to Precision Medicine Initiative that could not be detected Rahman, an immunologist obtain useful information and the New York Genome using single-cell RNA-seq at Icahn School of Medicine researchers need to know Center. Technologies that methods alone1. at Mount Sinai in New what they are looking for. combine single cell DNA or REAP-seq was first York. Rahman is developing RNA sequencing with methods employed to examine the innovative assays to monitor that provide details about the response of a T cell subset disease-relevant molecular “IT HAS BEEN regulation of gene expression, to a drug that activates the profiles and discover new EYE-OPENING TO protein expression, genetic immune system to attack biomarkers and drug targets. SEE HOW MUCH mutations, cell lineage, and and kill cancer cells in mice “In some cases, we have WE MIGHT even the spatiotemporal order by targeting a cell surface populations of cells that are all BE MISSING of molecular events not only protein. Differences between clearly expressing a particular BY USING allow the creation of a more the proteins and genes protein, but we may detect the CONVENTIONAL refined human cell atlas, but expressed in the treated and corresponding transcript in SEQUENCING.” offer new insights into cancer untreated cells provided only 5–10% of them,” evolution, neurodegeneration new insights into the drug’s he explains. and the immune system’s mechanism of action2. Rahman and others are In recent years, single response to disease. Since these studies were using techniques such as cell sequencing has become published, more than 200 CITE-seq (cellular indexing of the method of choice for Multimodal single cell oligo-conjugated antibodies transcriptomes and epitopes uncovering cell types sequencing in action have become available for by sequencing) and REAP- and states based on gene In CITE-seq and REAP-seq, CITE-seq and REAP-seq. seq (RNA expression and expression patterns. One of cells are incubated with These antibodies have been protein sequencing assay) to the advantages of single cell cell-surface antibodies used to assess immune investigate the relationship RNA (or DNA) sequencing is linked to oligonucleotide cell activation in patients between RNA transcripts that it is unbiased, it requires barcodes which tag the with advanced lung cancer and proteins, and identify no prior knowledge about protein’s identity, and a after immunotherapy3, new cell types and cell states the sample — RNA (or DNA) stretch of adenine bases that and to investigate associated with disease. Both from any cell type can be run serve as a starting point for immune dysregulations methods combine antibody- through a sequencer to obtain RNA sequencing (FIG). The at atherosclerotic sites oligonucleotides with existing its genomic or transcriptional technologies differ in the way associated with clinical single-cell RNA-sequencing profile. Advances in single- the DNA barcode binds to cerebrovascular events. (scRNA-seq) approaches to cell genomics are enabling the antibody. In both cases, When Rahman and measure the expression levels large scale projects such protein detection has been colleagues used CITE-seq of genes and cell-surface as the Human Cell Atlas shown to be as robust as by to examine the immune cell proteins in individual cells. Project, which aims to create flow cytometry. types in atherosclerotic Advertiser retains sole responsibility for content ADVERTISEMENT FEATURE lesions in stroke patients, blood contain the virus. active transcriptional tools are leading to a ‘second they found T cell subsets Moreover, HIV infected cells regulatory elements, wave’ of excitement around that were more activated, do not display any markers in nuclei obtained from single cell technologies. differentiated and that distinguish them from postmortem spinal cord cells “Now we can begin to really exhausted compared to uninfected cells, making to develop new treatments understand the complexity their blood counterparts. them practically impossible for spinal-cord disease of neurodegenerative Characterizing immune to detect and analyse. and injury. diseases, and the cell profiles with these ECCITE-seq can capture Rizvi is working closely contribution of multiple technologies could aid the the variability of T cell with bioinformaticians genes and variants to design of tailored therapies receptor sequences that and statisticians to disease processes in a and help predict a patient’s confer specificity for develop mathematical way that was not possible treatment response4. particular antigens. These approaches to harmonize before,” Maniatis adds. sequences are found at the Expanding the multimodal 5’ end of RNA molecules sequencing toolbox and are difficult to capture in “NOW WE CAN BEGIN TO REALLY Using the same concept scRNA-seq approaches that UNDERSTAND THE COMPLEXITY of DNA barcodes, CITE- profile the 3’ ends of RNAs. OF NEURODEGENERATIVE seq has been extended by Furthermore, this method DISEASES.” Peter Smibert and Neville can be expanded to capture Sanjana at the New York HIV RNA in the same cell. Genome Center to reveal “ECCITE-seq allows us to the data. “Multimodal Future outlook even more information tackle the heterogeneity, strategies enable us to Barcoding cellular content from single cells. ECCITE- rarity and the lack of marker make connections among is enabling researchers to seq (expanded CRISPR- in these cells, which is very simultaneously collected obtain multiple readouts compatible cellular indexing powerful,” she explains. measurements in any from single cells. As such, of transcriptomes and Ho and her team are cell type, and therefore they can characterize epitopes by sequencing), currently looking at cells in decipher key molecular cellular phenotypes can be used for the blood of HIV-infected events associated with the in more detail than by simultaneous detection of individuals during high- development, establishment using transcriptome the transcriptome, proteins, level viraemia and after and maintenance of neural measurements alone. clonotypes and CRISPR antiretroviral therapy to circuits,” he explains. These multi-omic readouts perturbations5. determine how infected When the team compares hold great potential to cells are able to continue the transcriptional advance translational dividing, leading to the clonal expression patterns from genomic science and “SINGLE CELL expansion of HIV-positive cells in cervical, thoracic and precision medicine. SEQUENCING cells. Understanding the lumbar regions of the spinal “We are also excited METHODS ARE features of these resistant cord, they see remarkable about the development PROVIDING AN clones may offer clues for differences. “Ultimately, of spatially resolved UNPRECEDENTED new therapies that
Load more

Recommended publications
  • Protein Sequencing Production of Ions for Mass Spectrometry
    Lecture 1 Introduction- Protein Sequencing Production of Ions for Mass Spectrometry Nancy Allbritton, M.D., Ph.D. Department of Physiology & Biophysics 824-9137 (office) [email protected] Office- Rm D349 Medical Science D Bldg. Introduction to Proteins Amino Acid- structural unit of a protein α carbon Amino acids- linked by peptide (amide) bond Amino Acids Proteins- 20 amino acids (Recall DNA- 4 bases) R groups- Varying size, shape, charge, H-bonding capacity, & chemical reactivity Introduction to Proteins Polypeptide Chain (Protein) - Many amino acids linked by peptide bonds By convention: Residue 1 starts at amino terminus. Polypeptides- a. Main chain i.e. regularly repeating portion b. Side chains- variable portion Introduction to Proteins 25,000 human genes >2X106 proteins Natural Proteins - Typically 50-2000 amino acids i.e. 550-220,000 molecular weight Over 200 different types of post-translational modifications. Ex: proteolysis, phosphorylation, acetylation, glycosylation S S S S S S Ex: Insulin Protein Complexity Is Very Large Over 200 different types of post-translational modifications. The Problem of Protein Sequencing. Edman Degradation: Step-wise cleavage of an amino acid from the amino terminus of a peptide. Alanine Gly 1 2 Reacts with uncharged NH3 1 2 Gly 1 2 Cyclizes & Releases in Mild Acid H N-Gly 2 2 2 PTH-Alanine Edman Degradation 1. Must be short peptide (<50 a.a.) amino acid release- 98% efficiency proteins- must fragment (CNBr or trypsin) Trypsin 2. Frequently fails due to a blocked amino terminus 3. Intolerant of impurities 4. Tedious & time consuming (hours-days) 1 amino acid cycle- 2 hours Solution: Mass Spectrometry 1.
    [Show full text]
  • 9 3 Innovirolgy Examples and Applications
    9.3: Examples and applications 1) Now that you have an understanding of the mechanisms behind the phage display system, let’s have a look at how it’s used in research. i) Phage display has a broad spectrum of applications. This can go from improvement of enzymes, to proteome analysis or drug and target discovery but is certainly not restricted to these. 2) The first thing I want to focus on is the optimization of enzymes. A large variety of enzymes are being used today in different fields of industry and biotech. These enzymes are originally made by organisms for a specific function in a specific niche or environment, like inside the cell cytoplasm. Therefore, they often have undesirable properties for the function or environment we want to use them in. They might not work fast enough, be unstable in the conditions they are used in or do not work on the desired substrate. Phage display can aid in improving these enzymes by selecting for example for better thermostability, activity or enhanced substrate binding. i) Let’s start with stability. Take for example an enzyme that is normally present In a cell at cytoplasm at 37°C. However when we use it in an industrial process where we need 50°C, the enzyme becomes unstable and denatures. In phage display we can make a library of mutagenized enzyme and display them on, in this case, the gene 3 protein of the phage. In the binding step of the biopanning most phages will not be able to bind the enzyme substrate at 50°C as they are denatured.
    [Show full text]
  • Single-Molecule Peptide Fingerprinting
    Single-molecule peptide fingerprinting Jetty van Ginkela,b, Mike Filiusa,b, Malwina Szczepaniaka,b, Pawel Tulinskia,b, Anne S. Meyera,b,1, and Chirlmin Joo (주철민)a,b,1 aKavli Institute of Nanoscience, Delft University of Technology, 2629HZ Delft, The Netherlands; and bDepartment of Bionanoscience, Delft University of Technology, 2629HZ Delft, The Netherlands Edited by Alan R. Fersht, Gonville and Caius College, Cambridge, United Kingdom, and approved February 21, 2018 (received for review May 1, 2017) Proteomic analyses provide essential information on molecular To obtain ordered determination of fluorescently labeled amino pathways of cellular systems and the state of a living organism. acids, we needed a molecular probe that can scan a peptide in a Mass spectrometry is currently the first choice for proteomic processive manner. We adopted a naturally existing molecular analysis. However, the requirement for a large amount of sample machinery, the AAA+ protease ClpXP from Escherichia coli.The renders a small-scale proteomics study challenging. Here, we ClpXP protein complex is an enzymatic motor that unfolds and demonstrate a proof of concept of single-molecule FRET-based degrades protein substrates. ClpX monomers form a homohexa- + protein fingerprinting. We harnessed the AAA protease ClpXP to meric ring (ClpX6) that can exercise a large mechanical force to scan peptides. By using donor fluorophore-labeled ClpP, we se- unfold proteins using ATP hydrolysis (11, 12). Through iterative quentially read out FRET signals from acceptor-labeled amino acids rounds of force-generating power strokes, ClpX6 translocates of peptides. The repurposed ClpXP exhibits unidirectional process- substrates through the center of its ring in a processive manner ing with high processivity and has the potential to detect low- (13, 14), with extensive promiscuity toward unnatural substrate abundance proteins.
    [Show full text]
  • Intrinsic Indicators for Specimen Degradation
    Laboratory Investigation (2013) 93, 242–253 & 2013 USCAP, Inc All rights reserved 0023-6837/13 $32.00 Intrinsic indicators for specimen degradation Jie Li1, Catherine Kil1, Kelly Considine1, Bartosz Smarkucki1, Michael C Stankewich1, Brian Balgley2 and Alexander O Vortmeyer1 Variable degrees of molecular degradation occur in human surgical specimens before clinical examination and severely affect analytical results. We therefore initiated an investigation to identify protein markers for tissue degradation assessment. We exposed 4 cell lines and 64 surgical/autopsy specimens to defined periods of time at room temperature before procurement (experimental cold ischemic time (CIT)-dependent tissue degradation model). Using two-dimen- sional fluorescence difference gel electrophoresis in conjunction with mass spectrometry, we performed comparative proteomic analyses on cells at different CIT exposures and identified proteins with CIT-dependent changes. The results were validated by testing clinical specimens with western blot analysis. We identified 26 proteins that underwent dynamic changes (characterized by continuous quantitative changes, isoelectric changes, and/or proteolytic cleavages) in our degradation model. These changes are strongly associated with the length of CIT. We demonstrate these proteins to represent universal tissue degradation indicators (TDIs) in clinical specimens. We also devised and implemented a unique degradation measure by calculating the quantitative ratio between TDIs’ intact forms and their respective degradation-
    [Show full text]
  • M.Sc. [Botany] 346 13
    cover page as mentioned below: below: mentioned Youas arepage instructedcover the to updateupdate to the coverinstructed pageare asYou mentioned below: Increase the font size of the Course Name. Name. 1. IncreaseCourse the theof fontsize sizefont ofthe the CourseIncrease 1. Name. use the following as a header in the Cover Page. Page. Cover 2. the usein the followingheader a as as a headerfollowing the inuse the 2. Cover Page. ALAGAPPAUNIVERSITY UNIVERSITYALAGAPPA [Accredited with ’A+’ Grade by NAAC (CGPA:3.64) in the Third Cycle Cycle Third the in (CGPA:3.64) [AccreditedNAAC by withGrade ’A+’’A+’ Gradewith by NAAC[Accredited (CGPA:3.64) in the Third Cycle and Graded as Category–I University by MHRD-UGC] MHRD-UGC] by University and Category–I Graded as as Graded Category–I and University by MHRD-UGC] M.Sc. [Botany] 003 630 – KARAIKUDIKARAIKUDI – 630 003 346 13 EDUCATION DIRECTORATEDISTANCE OF OF DISTANCEDIRECTORATE EDUCATION BIOLOGICAL TECHNIQUES IN BOTANY I - Semester BOTANY IN TECHNIQUES BIOLOGICAL M.Sc. [Botany] 346 13 cover page as mentioned below: below: mentioned Youas arepage instructedcover the to updateupdate to the coverinstructed pageare asYou mentioned below: Increase the font size of the Course Name. Name. 1. IncreaseCourse the theof fontsize sizefont ofthe the CourseIncrease 1. Name. use the following as a header in the Cover Page. Page. Cover 2. the usein the followingheader a as as a headerfollowing the inuse the 2. Cover Page. ALAGAPPAUNIVERSITY UNIVERSITYALAGAPPA [Accredited with ’A+’ Grade by NAAC (CGPA:3.64) in the Third Cycle Cycle Third the in (CGPA:3.64) [AccreditedNAAC by withGrade ’A+’’A+’ Gradewith by NAAC[Accredited (CGPA:3.64) in the Third Cycle and Graded as Category–I University by MHRD-UGC] MHRD-UGC] by University and Category–I Graded as as Graded Category–I and University by MHRD-UGC] M.Sc.
    [Show full text]
  • Electrophoresis
    B2144 Cover.qxd 9/1/98 8:10 AM Page 2 Ready Gel System RESOURCE GUIDE Bio-Rad Laboratories Life Science Australia, Bio-Rad Laboratories Pty Limited, Block Y Unit 1, Regents Park Industrial Estate, 391 Park Road, Regents Park, NSW 2143 • Group Phone 02-9914-2800 • Fax 02-9914-2889 Austria, Bio-Rad Laboratories Ges.m.b.H., Auhofstrasse 78D, A-1130 Wien • Phone (1) 877 89 01 • Fax (1) 876 56 29 Belgium, Bio-Rad Laboratories S.A.-N.V., Begoniastraat 5, B-9810 Nazareth EKE • Phone 09-385 55 11 • Fax 09-385 65 54 2000 Alfred Nobel Drive Canada, Bio-Rad Laboratories (Canada) Ltd., 5671 McAdam Road, Mississauga, Ontario L4Z 1N9 • Phone (905) 712-2771 • Fax (905) 712-2990 Hercules, California 94547 China, Bio-Rad China (Beijing), 14 Zhi Chun Road, Hai Dian District, Beijing 100 008 • Phone 86-10-62051850 • Fax 86-10-62051876 Telephone (510) 741-1000 Denmark, Bio-Rad Laboratories, Symbion Science Park, Fruebjergvej 3, DK-2100 København Ø • Phone 39 17 9947 • Fax 39 27 1698 Fax: (510) 741-5800 Finland, Bio-Rad Laboratories, Pihatörmä 1A 02240, Espoo, • Phone 90 804 2200 • Fax 90 804 1100 www.bio-rad.com France, Bio-Rad S.A., 94/96 rue Victor Hugo, B.P. 220, 94 203 Ivry Sur Seine Cedex • Phone (1) 43 90 46 90 • Fax (1) 46 71 24 67 Germany, Bio-Rad Laboratories GmbH, Heidemannstraße 164, D-80939 München • Phone 089 31884-0 • Fax 089 31884-100 Hong Kong, Bio-Rad Pacific Ltd., Unit 1111, 11/F., New Kowloon Plaza, 38 Tai Kok Tsui Road, Tai Kok Tsui, Kowloon, Hong Kong • Phone 852-2789-3300 • Fax 852-2789-1257 India, Bio-Rad Laboratories, India (Pvt.) Ltd., C-248 Defence Colony, New Delhi 110 024 • Phone 91-11-461-0103 • Fax 91-11-461-0765 Israel, Bio-Rad Laboratories Ltd., 12 Homa Street, P.O.
    [Show full text]
  • De Novo Peptide Sequencing Tutorial
    http://ionsource.com/tutorial/DeNovo/introduction.htm - De Novo Peptide Sequencing Tutorial 1 http://ionsource.com/tutorial/DeNovo/introduction.htm Table of Contents Introduction - Peptide Fragmentation Nomenclature - b and y Ions - The Rules (16 simple rules) - The Protocol - Example MS/MS Spectrum - • low mass • mid mass • high mass - First De Novo Exercise (Ion Trap Data) - • Answer Page - Second De Novo Exercise (q-TOF Data) - • Answer page • Tutorial References and Additional Suggested Reading - • De Novo Tables - AA Residue Mass, Mass Conflict, Di-peptide Mass Residue Combinations 2 http://ionsource.com/tutorial/DeNovo/introduction.htm 3 http://ionsource.com/tutorial/DeNovo/introduction.htm Introduction De novo is Latin for, "over again", or "anew". A popular definition for "de novo peptide sequen- cing" is, peptide sequencing performed without prior knowledge of the amino acid sequence. Usually this rule is imposed by Edman degradation practitioners who perform de novo sequencing day in and day out, and perhaps feel a little bit threatened by that half million dollar mass spectrometer sitting down the hall, that can supposedly sequence peptides in a matter of seconds, and not days. Actually, any research project should be started with as much information as pos- sible, there should never be a need to restrict your starting knowledge, unless of course you are performing a clinical trial or some other highly controlled experiment. Mass spectrometers do have the advantage when it comes to generating sequence data for peptides in low femtomole quantities. However, Edman degradation will always enjoy the advantage when pmol quantities of a peptide are available. At higher pmol quantities (2-10 pmol), Edman will often provide the exact amino acid sequence without ambiguity for a limited run of amino acids, 6-30 amino acids, usually taking 30-50 min per cycle of the sequencer.
    [Show full text]
  • UNIVERSITY of ALBERTA High Sensitivity Protein Sequencing
    UNIVERSITY OF ALBERTA High Sensitivity Protein Sequencing using Fluorescein Isothiocyanate for Denvatization on a Miniaturized Sequencer using Capillary EIectrophoresis with Laser hduced Fluorescence Detection for Prduct Identification. A thesis submitted to the Faculty of Graduate Studies and Research in partial Mfiment of the requirernents for the degree of Doctor of Philosophy. DEPARTMENT OF CHEMISTRY EDMONTON, ALBERTA, CANADA SPRING 2000 National Library Bibliothèque nationale 141 ,cm,, du Canada Acquisitions and Acquisitions et Bibtiographic Services services bibliographiques 395 Wellington Street 395. rue Wellington Ottawa ON K1A ON4 Ottawa ON K1A ON4 Canada Canada The author has granted a non- L'auteur a accordé une Licence non exclusive licence allowing the exclusive permettant à la National Lïbrary of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or selI reproduire, prêter, distribuer ou copies of this thesis in rnicroform, vendre des copies de cette thèse sous paper or electronic formats. la fonne de microfiche/fïlm, de reproduction sur papier ou sur format électronique. The author retauis ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fkom it Ni la thèse ni des extraits substantiels may be printed or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. For my Parents Primary sequence malysis is an important step in determining the strùctr;re- function relationship for a @en protein or peptide. By far the most popular sequencing method in use today is the Edman degradation.
    [Show full text]
  • Mass Spectrometry-Based De Novo Sequencing of the Anti-FLAG-M2 Antibody Using 2 Multiple Proteases and a Dual Fragmentation Scheme
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.07.425675; this version posted January 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Mass spectrometry-based de novo sequencing of the anti-FLAG-M2 antibody using 2 multiple proteases and a dual fragmentation scheme 3 4 Authors: 5 Weiwei Peng1#, Matti F. Pronker1#, Joost Snijder1* 6 7 #equal contribution 8 *corresponding author: [email protected] 9 10 Affiliation: 11 1 BioMolecular Mass SpectroMetry and ProteoMics, Bijvoet Center for BioMolecular Research 12 and Utrecht Institute of PharMaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH 13 Utrecht, The Netherlands 14 15 Keywords: 16 mass spectrometry, antibody, de novo sequencing, EThcD, stepped HCD, Herceptin, FLAG tag, 17 anti-FLAG-M2. 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.07.425675; this version posted January 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 18 Abstract: 19 Antibody sequence inforMation is crucial to understanding the structural basis for antigen binding 20 and enables the use of antibodies as therapeutics and research tools. Here we deMonstrate a 21 method for direct de novo sequencing of Monoclonal IgG from the purified antibody products.
    [Show full text]
  • Analysis of Transcript and Protein Overlap in a Human Osteosarcoma Cell Line
    Klevebring et al. BMC Genomics 2010, 11:684 http://www.biomedcentral.com/1471-2164/11/684 RESEARCH ARTICLE Open Access Analysis of transcript and protein overlap in a human osteosarcoma cell line Daniel Klevebring1,3, Linn Fagerberg2, Emma Lundberg2, Olof Emanuelsson1, Mathias Uhlén2, Joakim Lundeberg1* Abstract Background: An interesting field of research in genomics and proteomics is to compare the overlap between the transcriptome and the proteome. Recently, the tools to analyse gene and protein expression on a whole-genome scale have been improved, including the availability of the new generation sequencing instruments and high- throughput antibody-based methods to analyze the presence and localization of proteins. In this study, we used massive transcriptome sequencing (RNA-seq) to investigate the transcriptome of a human osteosarcoma cell line and compared the expression levels with in situ protein data obtained in-situ from antibody-based immunohistochemistry (IHC) and immunofluorescence microscopy (IF). Results: A large-scale analysis based on 2749 genes was performed, corresponding to approximately 13% of the protein coding genes in the human genome. We found the presence of both RNA and proteins to a large fraction of the analyzed genes with 60% of the analyzed human genes detected by all three methods. Only 34 genes (1.2%) were not detected on the transcriptional or protein level with any method. Our data suggest that the majority of the human genes are expressed at detectable transcript or protein levels in this cell line. Since the reliability of antibodies depends on possible cross-reactivity, we compared the RNA and protein data using antibodies with different reliability scores based on various criteria, including Western blot analysis.
    [Show full text]
  • Protein Detection & Identification Methods
    Protein Detection & Identification Methods October 24, 2007 MSB B554 Hong Li [email protected] 973-972-8396 Lecture notes: http://njms.umdnj.edu/proweb/lectures/note2007fall01.pdf Objectives 1. Protein analysis to determine: • Purity, quantity and identity • Expression and localization • Post-translational modification • Induction and turnover 2. Principles behind the analytical techniques • Based on unique physical/chemical properties; size, charge, etc. • Assays are based on reactions producing light, color and radio activities for detection 3. Techniques • Electrophoresis • Immunoblotting • Autoradiography • Mass spectrometry • Proteomics 1 Purity, quantity and identity Post-translational modification Induction and turnover Expression localization Basic Principles for Analysis (How to differentiate one protein from another?) Structure (Drs. Wang & Wah) Amino acid composition Post-translational modification (Dr. Wagner) Size Polarity/Charge/Hydrophobicity Shape Affinity (binding to other proteins/molecules) Function: catalytic activities 2 Shapes and sizes # of amino acids, composition & sequences Charges and polarity 3 Charges and polarity from post-translational modifications Reactivities of amino acids Physical/chemical reactions to facilitate colorimetric detection Example: Protein concentration assays: Bradford, BCA, Lowry & Biuret, etc. http://www-class.unl.edu/biochem/protein_assay/ 4 Bradford assay (Bio-Rad) Based on a dye binding to basic and aromatic amino acids Coommassie Brilliant Blue (CBB) G250 Protein binding
    [Show full text]
  • Green/Red Cyanobacteriochromes Regulate Complementary Chromatic Acclimation Via a Protochromic Photocycle
    Green/red cyanobacteriochromes regulate complementary chromatic acclimation via a protochromic photocycle Yuu Hirosea, Nathan C. Rockwellb, Kaori Nishiyamac, Rei Narikawad, Yutaka Ukajic, Katsuhiko Inomatac, J. Clark Lagariasb,1, and Masahiko Ikeuchid,1 aElectronics-Inspired Interdisciplinary Research Institute, Toyohashi University of Technology, Toyohashi, Aichi 441-8580, Japan; bDepartment of Molecular and Cellular Biology, University of California, Davis, CA 95616; cDivision of Material Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan; and dDepartment of Life Sciences (Biology), The University of Tokyo, Meguro, Tokyo 153-8902, Japan Contributed by J. Clark Lagarias, February 13, 2013 (sent for review January 24, 2013) Cyanobacteriochromes (CBCRs) are cyanobacterial members of the spectral diversity, with peak absorptions ranging from 330 to 680 phytochrome superfamily of photosensors. Like phytochromes, nm and hence spanning the entire visible spectrum and near UV CBCRs convert between two photostates by photoisomerization (13, 15–24). CBCR subfamilies that sense light in the near-UV to of a covalently bound linear tetrapyrrole (bilin) chromophore. blue region (330–470 nm) have been studied extensively. Such Although phytochromes are red/far-red sensors, CBCRs exhibit CBCRs combine bilin photoisomerization with subsequent for- diverse photocycles spanning the visible spectrum and the near- mation or elimination of a second thioether linkage to the bilin UV (330–680 nm). Two CBCR subfamilies detect near-UV to blue light C10 atom, shortening the conjugated π system to induce a re- (330–450 nm) via a “two-Cys photocycle” that couples bilin 15Z/15E markable spectral shift (19, 21, 23, 25–29). In such “two-Cys photoisomerization with formation or elimination of a second bilin– photocycles,” the reactive thiol group is supplied by a second cysteine adduct.
    [Show full text]